6Mouzaki A, Theodoropoulou M, Gianakopoulos I, Vlaha V, Kyrtsonis MC, et al. Expression patterns of TH1 and TH2 cytokine genes in childhood idiopathic thrombocytopenie purpura (ITP)at presentation and their modulation by intravenous immunoglobulin G (IVIG)treatment: their role in prognosis[ J]. Blood, 2002, 100 (5) :1774-1779.
3Musaji A,Cormont F,Thirion G,et al.Exacerbatiom of autoantibodymediated thrombocytopenic purpura by infection with mouse viruses.Blood,2004;104(7):2102.
4Tourneux P,Jouvencel P,Micheau M,et al.Parvovirus B19 thrombocytoperic purpura complicated with a cerebral hemorrhage.Arch Pediatr.2005;12(3):281.
5Cooper N,Heddle NM,Haas M,et al.Intravenous (Ⅳ) anti-D andⅣ immunoglobulin achieve acute platelet increases by different mechanisms:modulation of cytoline and platalet responses to Ⅳ anti-D by FcgammaR Ⅱ a and FcgammaR Ⅲ a polymorphisms.Br J Haematol,2004;124(4):511.
5Medeiros D, Buchanan GR. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood [ J ]. Pediatr Clin North Am, 1996, 43 (3) :757-772.
6Cines DB, MeMillan R. Management of adult idiopathic thrombocytopenic purpura[ J]. Annu Rev Med, 2005, 56:425-442.
7McMilan R. Classical management of refractory adult immune ( idiopathic) thrombocytopenic purpura [ J]. Blood Rev, 2002, 16 (1): 51-55.
8Zhang X, Rodriguez-Galan MC, Subleski JJ. Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells[ J]. Blood, 2004, (10) : 3276-84.
9Kanoh M, Uetani T, Sakan H. A two-step model of T cell subset commitment: antigen-independent commitment of T cells before encountering nominal antigen during pathogenic infections[ J ]. Int Immunol, 2002, 14 ( 6 ) :567-575.
10Iruretagoyena MI, Sepulveda SE, Lezana JP, Hermoso M, Brolffman M, Gutierrez MA, et al. Inhibition of nuclear factor- B enhances the capacity of immature dendritic cells to induce antigenspecific tolerance in experimental autoimmune encephalomyelitis [J]. JPET, 2006, 318(1) :59-67.
